共 50 条
- [1] Discovery of SAM competitive, brain-restricted PRMT5 inhibitors with potent antitumor activity[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255Tatlock, John论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USABillitti, Joseph论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USABraganza, John论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USABrooun, Alexei论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USADeng, Ya-Li论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAHirakawa, Brad论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAJensen-Pergakes, Kristen论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAKumpf, Robert论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USALiu, Wei论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAMaegley, Karen论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAMcAlpine, Indrawan论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAMcTigue, Michele论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAPatman, Ryan论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USARui, Eugene论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAScales, Stephanie论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USATran-Dube, Michelle论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAWang, Fen论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAWang, Zhenxiong论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAYamazaki, Shinji论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAZhang, Tao论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAWythes, Martin论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA
- [2] Discovery of SAM competitive and non-nucleoside derivative PRMT5 inhibitors with potent antitumor activity[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257Yang, Xiaozhi论文数: 0 引用数: 0 h-index: 0机构: Univ Florida, Med Chem, Gainesville, FL USA Univ Florida, Med Chem, Gainesville, FL USAZhou, Wei论文数: 0 引用数: 0 h-index: 0机构: Univ Florida, Gainesville, FL USA Univ Florida, Med Chem, Gainesville, FL USALi, Chenglong论文数: 0 引用数: 0 h-index: 0机构: Univ Florida, Med Chem, Gainesville, FL USA Univ Florida, Med Chem, Gainesville, FL USA
- [3] SAM competitive PRMT5 inhibitor PF06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance.[J]. CANCER RESEARCH, 2021, 81 (13)Jensen-Pergakes, Kristen论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USATatlock, John论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAMaegley, Karen论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAMcAlpine, Indrawan论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAMcTigue, Michele论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAXie, Tao论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USADillon, Christopher论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAWang, Yuli论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAYamazaki, Shinji论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USASpiegel, Noah论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAShi, Manli论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USANemeth, Amy论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAMiller, Natalie论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAHendrickson, Eleanore论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USALam, Hieu论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USASherrill, John论文数: 0 引用数: 0 h-index: 0机构: Cedilla Therapeut, Cambridge, MA USA Pfizer, San Diego, CA USALiu, Wei论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USADeng, Ya-Li论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAChung, Chi-Yeh论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAMcMillan, Elizabeth A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAPalde, Prakash论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USABrooun, Alexei论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, West Point, PA USA Pfizer, San Diego, CA USABraganza, John论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAKephart, Susan E.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAKumpf, Robert论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAPatman, Ryan论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USARui, Eugene论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAScales, Stephanie论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USATran-Dube, Michelle论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAWang, Fen论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAWythes, Martin论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USAPaul, Thomas论文数: 0 引用数: 0 h-index: 0机构: Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA
- [4] SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance[J]. MOLECULAR CANCER THERAPEUTICS, 2022, 21 (01) : 3 - 15Jensen-Pergakes, Kristen论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USATatlock, John论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAMaegley, Karen A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAMcAlpine, Indrawan J.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAMcTigue, Michele论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAXie, Tao论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USADillon, Christopher P.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAWang, Yuli论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAYamazaki, Shinji论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Pharmacokinet Dynam & Metab, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USASpiegel, Noah论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAShi, Manli论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USANemeth, Amy论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAMiller, Natalie论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAHendrickson, Eleanore论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAHieu Lam论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USASherrill, John论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAChung, Chi-Yeh论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAMcMillan, Elizabeth A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USABryant, Shannon Karlicek论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAPalde, Prakash论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USABraganza, John论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USABrooun, Alexei论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USADeng, Ya-Li论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAGoshtasbi, Vesta论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAKephart, Susan E.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAKumpf, Robert A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USALiu, Wei论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAPatman, Ryan L.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USARui, Eugene论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAScales, Stephanie论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USATran-Dube, Michelle论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAWang, Fen论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAWythes, Martin论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Med Chem, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USAPaul, Thomas A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Div, San Diego, CA 92121 USA
- [5] The discovery and preclinical characterization of the SAM-competitive PRMT5 inhibitor UCT-000445[J]. CANCER RESEARCH, 2023, 83 (07)McDermott, Martina S.论文数: 0 引用数: 0 h-index: 0O'Brien, Neil A.论文数: 0 引用数: 0 h-index: 0O'Boyle, Brendan论文数: 0 引用数: 0 h-index: 0Bartberger, Michael论文数: 0 引用数: 0 h-index: 0Loson, Oliver C.论文数: 0 引用数: 0 h-index: 0Chau, Kevin论文数: 0 引用数: 0 h-index: 0Schwab, Ella论文数: 0 引用数: 0 h-index: 0Hong, Jenny论文数: 0 引用数: 0 h-index: 0Zhou, Jiaying论文数: 0 引用数: 0 h-index: 0Hu, Chuhong论文数: 0 引用数: 0 h-index: 0Luo, Tong论文数: 0 引用数: 0 h-index: 0Ayala, Raul论文数: 0 引用数: 0 h-index: 0Glasby, John论文数: 0 引用数: 0 h-index: 0Stoltz, Brian M.论文数: 0 引用数: 0 h-index: 0Slamon, Dennis J.论文数: 0 引用数: 0 h-index: 0
- [6] LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (07): : 612 - 617Bonday, Zahid Q.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USACortez, Guillermo S.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAGrogan, Michael J.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAAntonysamy, Stephen论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAWeichert, Ken论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USABocchinfuso, Wayne P.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USALi, Fengling论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAKennedy, Steven论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USALi, Binghui论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAMader, Mary M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAArrowsmith, Cheryl H.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada Univ Toronto, Dept Med Biophys, 101 Coll St,MaRS South Tower,Suite 707, Toronto, ON M5G 1L7, Canada Princess Margaret Canc Ctr, 101 Coll St,MaRS South Tower,Suite 707, Toronto, ON M5G 1L7, Canada Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USABrown, Peter J.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAEram, Mohammad S.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USASzewczyk, Magdalena M.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USABarsyte-Lovejoy, Dalia论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAVedadi, Masoud论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAGuccione, Ernesto论文数: 0 引用数: 0 h-index: 0机构: Inst Mol & Cell Biol, Singapore 138673, Singapore Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USACampbell, Robert M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
- [7] Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity[J]. MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12) : 2317 - 2328Brehmer, Dirk论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumBeke, Lijs论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumWu, Tongfei论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumMillar, Hillary J.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumMoy, Christopher论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Janssen Res & Dev, Antwerp, BelgiumSun, Weimei论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Janssen Res & Dev, Antwerp, BelgiumMannens, Geert论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumPande, Vineet论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumBoeckx, An论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, Belgiumvan Heerde, Erika论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumNys, Thomas论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumGustin, Emmanuel M.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumVerbist, Bie论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumZhou, Longen论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Shanghai, Peoples R China Janssen Res & Dev, Antwerp, BelgiumFan, Yue论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Shanghai, Peoples R China Janssen Res & Dev, Antwerp, BelgiumBhargava, Vipul论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Janssen Res & Dev, Antwerp, BelgiumSafabakhsh, Pegah论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Janssen Res & Dev, Antwerp, BelgiumVinken, Petra论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumVerhulst, Tinne论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumGilbert, Angelique论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Charlestown, MA USA Janssen Res & Dev, Antwerp, BelgiumRai, Sumit论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Charlestown, MA USA Janssen Res & Dev, Antwerp, BelgiumGraubert, Timothy A.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Charlestown, MA USA Janssen Res & Dev, Antwerp, BelgiumPastore, Friederike论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Janssen Res & Dev, Antwerp, BelgiumFiore, Danilo论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumGu, Junchen论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Janssen Res & Dev, Antwerp, BelgiumJohnson, Amy论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Janssen Res & Dev, Antwerp, BelgiumPhilippar, Ulrike论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumMorschhauser, Barbara论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumWalker, David论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Janssen Res & Dev, Antwerp, BelgiumDe Lange, Desiree论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumKeersmaekers, Vikki论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumViellevoye, Marcel论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumDiels, Gaston论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumSchepens, Wim论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumThuring, Jan Willem论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumMeerpoel, Lieven论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Antwerp, Belgium Janssen Res & Dev, Antwerp, BelgiumPackman, Kathryn论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Janssen Res & Dev, Antwerp, BelgiumLorenzi, Matthew V.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Janssen Res & Dev, Antwerp, BelgiumLaquerre, Sylvie论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Janssen Res & Dev, Antwerp, Belgium
- [8] AGX323-A SAM-competitive, orally available inhibitor of protein arginine methyltransferase 5 (PRMT5) with potent cellular antiproliferative and in vivo antitumor activity against selected solid cancer types.[J]. CANCER RESEARCH, 2021, 81 (13)Lee, Francis Y. F.论文数: 0 引用数: 0 h-index: 0机构: Angex Pharmaceutical Inc, North Brunswick, NJ USA Angex Pharmaceutical Inc, North Brunswick, NJ USAWu, Wen-Lian论文数: 0 引用数: 0 h-index: 0机构: Angex Pharmaceutical Inc, North Brunswick, NJ USA Angex Pharmaceutical Inc, North Brunswick, NJ USAYang, Zhiqiang论文数: 0 引用数: 0 h-index: 0机构: Angex Pharmaceutical Inc, North Brunswick, NJ USA Angex Pharmaceutical Inc, North Brunswick, NJ USATan, John论文数: 0 引用数: 0 h-index: 0机构: Angex Pharmaceutical Inc, North Brunswick, NJ USA Angex Pharmaceutical Inc, North Brunswick, NJ USA
- [9] A novel MTA non-competitive PRMT5 inhibitor.[J]. CANCER RESEARCH, 2021, 81 (13)Malik, Rohit论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Redwood City, CA USA Bristol Myers Squibb Co, Redwood City, CA USAPark, Peter K.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USABarbieri, Christopher M.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USABlat, Yuval论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USASheriff, Steven论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAWeigelt, Carolyn A.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAKopcho, Lisa M.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USACeliktas, Muge论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Redwood City, CA USA Bristol Myers Squibb Co, Redwood City, CA USARuzanov, Max论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USANaglich, Joseph G.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAPrice, Jennifer L.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAHarner, Mary论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAOmalley, Kevin M.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USADeng, Jingjing论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USASchmitz, William论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USALi, Guo论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USARuan, Zheming论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAQin, Lan-ying论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USADuke, Gerald J.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USARodrigo, Iyoncy论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAWitmer, Mark R.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAHarden, David G.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USADemes, Shilpa论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAArey, Brian J.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USASoars, Matt论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Cambridge, MA USA Bristol Myers Squibb Co, Redwood City, CA USAFink, Brian E.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAGavai, Ashvinikumar V.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAVite, Gregory D.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Princeton, NJ USA Bristol Myers Squibb Co, Redwood City, CA USAVoliva, Charles F.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb Co, Redwood City, CA USA Bristol Myers Squibb Co, Redwood City, CA USA
- [10] A novel PRMT5 inhibitor with potent in vitro and in vivo activity in preclinical lung cancer models[J]. CANCER RESEARCH, 2017, 77Brehmer, Dirk论文数: 0 引用数: 0 h-index: 0Wu, Tongfei论文数: 0 引用数: 0 h-index: 0Mannens, Geert论文数: 0 引用数: 0 h-index: 0Beke, Lijs论文数: 0 引用数: 0 h-index: 0Vinken, Petra论文数: 0 引用数: 0 h-index: 0Gaffney, Dana论文数: 0 引用数: 0 h-index: 0Sun, Weimei论文数: 0 引用数: 0 h-index: 0Pande, Vineet论文数: 0 引用数: 0 h-index: 0Thuring, Jan-Willem论文数: 0 引用数: 0 h-index: 0Millar, Hillary论文数: 0 引用数: 0 h-index: 0Poggesi, Italo论文数: 0 引用数: 0 h-index: 0Somers, Ivan论文数: 0 引用数: 0 h-index: 0Boeckx, An论文数: 0 引用数: 0 h-index: 0Parade, Marc论文数: 0 引用数: 0 h-index: 0van Heerde, Erika论文数: 0 引用数: 0 h-index: 0Nys, Thomas论文数: 0 引用数: 0 h-index: 0Yanovich, Carol论文数: 0 引用数: 0 h-index: 0Herkert, Barbara论文数: 0 引用数: 0 h-index: 0Verhulst, Tinne论文数: 0 引用数: 0 h-index: 0Du Jardin, Marc论文数: 0 引用数: 0 h-index: 0Meerpoel, Lieven论文数: 0 引用数: 0 h-index: 0Moy, Christopher论文数: 0 引用数: 0 h-index: 0Diels, Gaston论文数: 0 引用数: 0 h-index: 0Viellevoye, Marcel论文数: 0 引用数: 0 h-index: 0Schepens, Wim论文数: 0 引用数: 0 h-index: 0Poncelet, Alain论文数: 0 引用数: 0 h-index: 0Linders, Joannes T.论文数: 0 引用数: 0 h-index: 0Lawson, Edward C.论文数: 0 引用数: 0 h-index: 0Edwards, James P.论文数: 0 引用数: 0 h-index: 0Chetty, Dushen论文数: 0 引用数: 0 h-index: 0Laquerre, Sylvie论文数: 0 引用数: 0 h-index: 0Lorenzi, Matthew V.论文数: 0 引用数: 0 h-index: 0